D-1043-2018 Class II Terminated
FDA drug recall D-1043-2018 was initiated by PharMEDium Services, LLC on Jul 24, 2018 and is designated Class II. Reason for recall: CGMP deviations: Product was released while a hood certification discrepancy was being investigated. The recall status is terminated (terminated Dec 10, 2018). Affected quantity: 230 Intravia Bags.
Recall Details
- Product Type
- Drugs
- Report Date
- Aug 15, 2018
- Initiation Date
- Jul 24, 2018
- Termination Date
- Dec 10, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 230 Intravia Bags
Product Description
10 mcg/mL Fentanyl Citrate (Preservative Free) in 0.9% Sodium Chloride 250 mL in 250 mL Intravia Bag and 10 mcg/mL Fentanyl Citrate (Preservative Free) in 0.9% Sodium Chloride 100 mL in 150 mL Intravia Bag, PharMEDium Services, LLC.
Reason for Recall
CGMP deviations: Product was released while a hood certification discrepancy was being investigated.
Distribution Pattern
Product was distributed throughout the United States
Code Information
Lot 181760013D, 181730007D, Exp 08/09/2018, 09/02/2018
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1043-2018
- openFDA file date
- Oct 23, 2026
- Loaded by RegDataLab
- Oct 25, 2026